Professional profile and expectations of members associated to Pharmaceutical Care in Infectious Diseases group of the Spanish Society of Hospital Pharmacy [0.03%]
西班牙医院药学学会感染病药物治疗组成员的职业档案及期望值
Iván Oterino-Moreira,Álvaro-Eloy Monje-López,Beatriz Mejuto et al.
Iván Oterino-Moreira et al.
Background: The Pharmaceutical Care in Infectious Diseases Group (AFinf) is composed of a coordinating group of 11 pharmacists, 1 fellow, 1 resident pharmacist intern, 4 senior consultants and 221 associate members (July ...
Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer [0.03%]
度伐利尤单抗联合卡铂和依托泊苷治疗广泛期小细胞肺癌的疗效和安全性分析
María Belén Aznar de la Riera,Carmen María Valencia Soto,Adela García-Avello Fernández-Cueto et al.
María Belén Aznar de la Riera et al.
Objective: The objective is to describe the real-world effectiveness and safety of atezolizumab in combination with carboplatin and etoposide as first-line treatment for patients with extensive-stage small-cell lung cance...
Application of the Basel Statements self-assessment questionnaire in eight hospitals in Latin America [0.03%]
巴塞尔声明自我评估问卷在拉丁美洲8家医院的应用
Esteban Zavaleta-Monestel,Arturo Villalobos-Madriz,Abigail Fallas-Mora et al.
Esteban Zavaleta-Monestel et al.
The standardization of hospital pharmacy practice remains a challenge in Latin America due to the heterogeneity of healthcare systems. The Basel Statements, developed by the International Pharmaceutical Federation, provide guidelines aimed ...
Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice [0.03%]
用于年龄相关性黄斑变性的faricimab给药间隔优化和治疗依从性：真实世界临床实践中的观察性研究
Silvia Cornejo-Uixeda,Joaquín Borrás-Blasco,Alejandro Valcuende-Rosique et al.
Silvia Cornejo-Uixeda et al.
Objective: To evaluate treatment persistence and dosing interval extension with faricimab in neovascular age-related macular degeneration (nAMD) in real-world practice. ...
Safety of Bruton kinase inhibitors in chronic lymphocytic leukemia: Real world clinical practice [0.03%]
布鲁顿酪氨酸激酶抑制剂在慢性淋巴细胞白血病患者中的安全性：临床实践报告
Rocío Bello-Calvo,Rita González-Resina,Araceli Rubio-Martínez et al.
Rocío Bello-Calvo et al.
Introduction: Bruton's tyrosine kinase inhibitors (BTKi) have replaced immunochemotherapy in patients with chronic lymphocytic leukemia (CLL). The safety profile, particularly in monotherapy indications under real-world c...
In vitro assay of pharmacobezoar formation with extended-release divalproex sodium tablets [0.03%]
宁格替必片剂体外药块形成试验研究
Thais Lizondo López,Silvia González Suárez,Carmen López-Cabezas et al.
Thais Lizondo López et al.
Objective: To assess pharmacobezoar formation in a case of intoxication following the massive ingestion of extended-release divalproex sodium tablets, using an in vitro model conducted in the pharmacy laboratory. ...
Sterility of repackaged faricimab for intravitreal administration [0.03%]
预充式注射器远藤素单抗的无菌保障水平验证研究报告摘要
Antonio Raymundo,Lourdes Cervera,Francisco Crespillo et al.
Antonio Raymundo et al.
Objectives: New drugs such as faricimab have been developed to treat ophthalmic neovascular diseases. While these drugs increase treatment success, they also increase costs. Repackaging drugs strikes a balance between tec...
The role of digital tools and artificial intelligence in supporting antimicrobial stewardship: Study protocol for a systematic review [0.03%]
数字化工具和人工智能在抗菌药物管理中的作用：系统评价方案
Carlos José Cortés Sánchez,Fernando Salazar González,José María Gómez Portolés et al.
Carlos José Cortés Sánchez et al.
Introduction: Since the post-antibiotic era, there has been significant difficulty in treating infectious diseases due to the increase in antimicrobial resistance, the scarcity of new antimicrobials, and the complexity of...
Methodological interpretation of subgroup analysis by histological subtype for perioperative toripalimab in resectable non-small-cell lung cancer [0.03%]
特瑞普利单抗围手术期治疗可切除非小细胞肺癌不同组织学亚型的疗效分析及方法学解读
Manuel David Gil-Sierra,Elisa Pizarro-Barron,Maria Del Pilar Briceño-Casado
Manuel David Gil-Sierra
Objective: Pivotal study on perioperative toripalimab in resectable non-small-cell lung cancer showed population differences by histological subtype compared with other immunotherapy regimens, raising doubts about therape...
Reply to comments on the PSICU-ALTA protocol: first steps toward improving psychotropic prescribing after ICU discharge [0.03%]
关于PSICU-ALTA方案的评论答复：改善重症监护病房出院后精神药物处方的第一步
Laura Doménech-Moral,Javier Santader-Reboreda,Meri Martin-Cerezuela et al.
Laura Doménech-Moral et al.